Biotech comes to its 'antisenses' after hard-won drug approval

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jiang, K. Biotech comes to its 'antisenses' after hard-won drug approval. Nat Med 19, 252 (2013). https://doi.org/10.1038/nm0313-252

Download citation

Further reading